Drug Approval Package

Exelon Patch (rivastigmine transdermal system)
Company:  Novartis Pharmaceuticals Corporation
Application No.:  022083
Approval Date: 7/6/2007

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

• Approval Letter(s) (PDF)
• Printed Labeling (PDF)
• Medical Review(s)
  • Part 1 (PDF)
  • Part 2 (PDF)
• Chemistry Review(s) (PDF)
• Pharmacology Review(s)
  • Part 1 (PDF)
  • Part 2 (PDF)
• Statistical Review(s) (PDF)
• Clinical Pharmacology Biopharmaceutics Review(s)
  • Part 1 (PDF)
  • Part 2 (PDF)
• Proprietary Name Review(s) (PDF)
• Administrative Document(s) & Correspondence (PDF)

Date created: May 28, 2009

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.